| Immunology in the liver—from homeostasis to disease F Heymann, F Tacke Nature reviews Gastroenterology & hepatology 13 (2), 88-110, 2016 | 998 | 2016 |
| Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury C Baeck, A Wehr, KR Karlmark, F Heymann, M Vucur, N Gassler, S Huss, ... Gut 61 (3), 416-426, 2012 | 636 | 2012 |
| Liver inflammation abrogates immunological tolerance induced by Kupffer cells F Heymann, J Peusquens, I Ludwig‐Portugall, M Kohlhepp, C Ergen, ... Hepatology 62 (1), 279-291, 2015 | 386 | 2015 |
| Role of IL‐17 and Th17 cells in liver diseases L Hammerich, F Heymann, F Tacke Journal of Immunology Research 2011 (1), 345803, 2011 | 329 | 2011 |
| Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury JC Mossanen, O Krenkel, C Ergen, O Govaere, A Liepelt, T Puengel, ... Hepatology 64 (5), 1667-1682, 2016 | 319 | 2016 |
| The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis HJ Paust, JE Turner, OM Steinmetz, A Peters, F Heymann, C Ho, G Wolf, ... Journal of the American Society of Nephrology 20 (5), 969-979, 2009 | 305 | 2009 |
| Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis A Wehr, C Baeck, F Heymann, PM Niemietz, L Hammerich, C Martin, ... The Journal of Immunology 190 (10), 5226-5236, 2013 | 286 | 2013 |
| Monocytes and macrophages as cellular targets in liver fibrosis F Heymann, C Trautwein, F Tacke Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2009 | 272 | 2009 |
| Pharmacological inhibition of the chemokine C‐C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly‐6C+ … C Baeck, X Wei, M Bartneck, V Fech, F Heymann, N Gassler, K Hittatiya, ... Hepatology 59 (3), 1060-1072, 2014 | 269 | 2014 |
| TAK1 suppresses a NEMO-dependent but NF-κB-independent pathway to liver cancer K Bettermann, M Vucur, J Haybaeck, C Koppe, J Janssen, F Heymann, ... Cancer cell 17 (5), 481-496, 2010 | 260 | 2010 |
| Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury F Heymann, C Meyer-Schwesinger, EE Hamilton-Williams, L Hammerich, ... The Journal of clinical investigation 119 (5), 1286-1297, 2009 | 254 | 2009 |
| M-CSF and GM-CSF receptor signaling differentially regulate monocyte maturation and macrophage polarization in the tumor microenvironment E Van Overmeire, B Stijlemans, F Heymann, J Keirsse, Y Morias, Y Elkrim, ... Cancer research 76 (1), 35-42, 2016 | 243 | 2016 |
| The concanavalin A model of acute hepatitis in mice F Heymann, K Hamesch, R Weiskirchen, F Tacke Laboratory animals 49 (1_suppl), 12-20, 2015 | 238 | 2015 |
| Differential effects of selective-and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆ S Lefere, T Puengel, J Hundertmark, C Penners, AK Frank, A Guillot, ... Journal of hepatology 73 (4), 757-770, 2020 | 203 | 2020 |
| Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis L Hammerich, JM Bangen, O Govaere, HW Zimmermann, N Gassler, ... Hepatology 59 (2), 630-642, 2014 | 196 | 2014 |
| Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice F Heymann, L Hammerich, D Storch, M Bartneck, S Huss, V Rüsseler, ... Hepatology 55 (3), 898-909, 2012 | 187 | 2012 |
| Peptide-functionalized gold nanorods increase liver injury in hepatitis M Bartneck, T Ritz, HA Keul, M Wambach, J Bornemann, U Gbureck, ... Acs Nano 6 (10), 8767-8777, 2012 | 168 | 2012 |
| Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries J Bábíčková, BM Klinkhammer, EM Buhl, S Djudjaj, M Hoss, F Heymann, ... Kidney international 91 (1), 70-85, 2017 | 163 | 2017 |
| Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice U Panzer, OM Steinmetz, HJ Paust, C Meyer-Schwesinger, A Peters, ... Journal of the American Society of Nephrology 18 (7), 2071-2084, 2007 | 129 | 2007 |
| CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis KM Schneider, V Bieghs, F Heymann, W Hu, D Dreymueller, L Liao, ... Hepatology 62 (5), 1405-1416, 2015 | 111 | 2015 |
